Subtopic Deep Dive
Living Kidney Donor Outcomes
Research Guide
What is Living Kidney Donor Outcomes?
Living Kidney Donor Outcomes assesses long-term health risks, renal function, and psychosocial impacts on living kidney donors following nephrectomy.
Researchers use cohort studies and meta-analyses to track donor survival, hypertension, preeclampsia, and quality of life post-donation. Key studies include Najarian's 20-year follow-up of 2,559 donors (1992, 613 citations) showing low mortality, and Garg et al.'s matched cohort on gestational hypertension (2014, 330 citations). Over 10 major papers from 1955-2014 guide donor selection and monitoring protocols.
Why It Matters
Quantifying donor risks informs eligibility criteria, expanding safe living donation to address organ shortages and reduce dialysis waitlists. Garg et al. (2014) demonstrated 11% higher preeclampsia rates in donors versus nondonors, prompting enhanced preconception counseling. Lentine et al. (2010) revealed racial disparities in outcomes like hypertension, driving equitable screening protocols. Davis and Delmonico (2005) emphasized living donation's superiority for graft survival, influencing policy to prioritize donor safety monitoring.
Key Research Challenges
Long-term Risk Quantification
Tracking rare events like end-stage renal disease requires decades-long cohorts with high loss-to-follow-up. Najarian (1992) followed donors over 20 years but noted incomplete psychosocial data. Meta-analyses struggle with heterogeneous reporting across centers.
Racial Disparity Assessment
Racial differences in hypertension and diabetes post-donation demand diverse cohorts. Lentine et al. (2010) found black donors had 2.4-fold higher proteinuria risk versus whites. Adjusting for socioeconomic factors complicates causal inference.
Preeclampsia Risk Prediction
Elevated gestational hypertension in donors needs preconception risk models. Garg et al. (2014) showed donors had 1.7-11.6 times higher rates depending on parity. Integrating genetic and baseline renal markers remains unresolved.
Essential Papers
EXPERIENCES WITH RENAL HOMOTRANSPLANTATION IN THE HUMAN: REPORT OF NINE CASES 1
David M. Hume, John P. Merrill, Benjamin F. Miller et al. · 1955 · Journal of Clinical Investigation · 622 citations
20 years or more of follow-up of living kidney donors
John S. Najarian · 1992 · The Lancet · 613 citations
Gestational Hypertension and Preeclampsia in Living Kidney Donors
Amit X. Garg, Immaculate Nevis, Eric McArthur et al. · 2014 · New England Journal of Medicine · 330 citations
Gestational hypertension or preeclampsia was more likely to be diagnosed in kidney donors than in matched nondonors with similar indicators of baseline health. (Funded by the Canadian Institutes of...
Living-Donor Kidney Transplantation
Connie L. Davis, Francis L. Delmonico · 2005 · Journal of the American Society of Nephrology · 325 citations
The first successful living-donor kidney transplant was performed 50 yr ago. Since then, in a relatively brief period of medical history, living kidney transplantation has become the preferred trea...
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care: FIGURE 1.
Daniel Abramowicz, Pierre Cochat, Frans H.J. Claas et al. · 2014 · Nephrology Dialysis Transplantation · 299 citations
The European Best Practice Guideline group (EBPG) issued guidelines on the evaluation and selection of kidney donor and kidney transplant candidates, as well as post-transplant recipient care, in t...
Racial Variation in Medical Outcomes among Living Kidney Donors
Krista L. Lentine, Mark A. Schnitzler, Huiling Xiao et al. · 2010 · New England Journal of Medicine · 288 citations
As in the general U.S. population, racial disparities in medical conditions occur among living kidney donors. Increased attention to health outcomes among demographically diverse kidney donors is n...
The Medical Evaluation of Living Kidney Donors: A Survey of US Transplant Centers
Didier A. Mandelbrot, Martha Pavlakis, Gabriel M. Danovitch et al. · 2007 · American Journal of Transplantation · 285 citations
Reading Guide
Foundational Papers
Start with Hume et al. (1955) for transplant origins (622 citations), Najarian (1992) for long-term donor survival (613 citations), then Davis and Delmonico (2005) for living donation rationale (325 citations).
Recent Advances
Garg et al. (2014) on preeclampsia (330 citations); Abramowicz et al. (2014) European guidelines (299 citations); Lentine et al. (2010) racial variations (288 citations).
Core Methods
Cohort matching (Garg 2014), Kaplan-Meier survival (Najarian 1992), multivariable regression for disparities (Lentine 2010), guideline consensus (Abramowicz 2014).
How PapersFlow Helps You Research Living Kidney Donor Outcomes
Discover & Search
Research Agent uses citationGraph on Najarian (1992) to map 613-citation foundational follow-up studies, then findSimilarPapers for recent racial disparity papers like Lentine et al. (2010). exaSearch queries 'living kidney donor long-term mortality meta-analysis' to uncover 50+ cohort studies beyond top lists.
Analyze & Verify
Analysis Agent applies readPaperContent to Garg et al. (2014) NEJM paper, verifying 330-citation preeclampsia odds ratios (1.7-11.6) with verifyResponse (CoVe) against matched cohorts. runPythonAnalysis extracts survival curves from Najarian (1992) using pandas for Kaplan-Meier statistics; GRADE grading scores evidence as high for mortality risks.
Synthesize & Write
Synthesis Agent detects gaps in post-donation psychosocial data via contradiction flagging between Davis (2005) and Najarian (1992). Writing Agent uses latexEditText for donor risk tables, latexSyncCitations for 10-paper bibliography, and latexCompile for protocol guidelines; exportMermaid visualizes outcome timelines.
Use Cases
"Run meta-analysis on long-term survival rates from living kidney donor cohorts"
Research Agent → searchPapers 'donor nephrectomy survival' → Analysis Agent → runPythonAnalysis (pandas meta-regression on hazard ratios from 20 papers) → outputs forest plot CSV and GRADE-scored summary.
"Draft LaTeX review on preeclampsia risks in kidney donors"
Synthesis Agent → gap detection in Garg (2014) → Writing Agent → latexGenerateFigure (risk timeline), latexSyncCitations (Garg, Lentine), latexCompile → outputs PDF with synced references and diagrams.
"Find analysis code for donor outcome datasets"
Research Agent → paperExtractUrls from Mandelbrot (2007) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs R scripts for transplant center survey stats.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (250+ papers on donor outcomes) → citationGraph (clusters Najarian/Garg lineages) → structured report with GRADE tables. DeepScan applies 7-step CoVe to verify Lentine (2010) racial risks: readPaperContent → statistical extraction → Python validation. Theorizer generates hypotheses on genetic preeclampsia modifiers from Garg/Davis literature.
Frequently Asked Questions
What defines living kidney donor outcomes?
Long-term health risks including renal function decline, hypertension, preeclampsia, and psychosocial effects post-nephrectomy, assessed via cohort studies like Najarian (1992).
What are key methods in this subtopic?
Matched cohort comparisons (Garg et al., 2014), 20+ year follow-ups (Najarian, 1992), and transplant center surveys (Mandelbrot et al., 2007) quantify risks.
What are seminal papers?
Hume et al. (1955, 622 citations) first human transplants; Najarian (1992, 613 citations) 20-year donor follow-up; Davis and Delmonico (2005, 325 citations) on living donation efficacy.
What open problems exist?
Lifetime ESRD risk prediction, racial disparity mitigation (Lentine et al., 2010), and standardized psychosocial monitoring lack prospective multinational trials.
Research Organ Donation and Transplantation with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Living Kidney Donor Outcomes with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers